Skip to main content
See every side of every news story
Published loading...Updated

Eli Lilly announces $6.5B manufacturing plant in Houston, boosting investment from initial proposal

Eli Lilly's $6.5 billion Houston facility will create 615 permanent jobs and 4,000 construction roles to produce small molecule medicines including the oral obesity drug orforglipron.

  • Eli Lilly plans to build a new $6.5 billion manufacturing facility for small molecule drugs in Houston, Texas.
  • The facility will focus on producing Eli Lilly's potential obesity and diabetes drug orforglipron and create 615 new jobs in the area.
  • Construction on the 236-acre site is expected to begin this year and be completed within 5 years, generating around 4,000 construction jobs.
Insights by Ground AI

42 Articles

Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 90% of the sources are Center
90% Center

Factuality 

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

Due broke the news in on Thursday, September 18, 2025.
Sources are mostly out of (0)
News
For You
Search
BlindspotLocal